Bayer drops challenge over patent extension for contraceptive drug

Intellectual Property 2022-05-09 1:13 pm By Cat Fredenburgh | Melbourne

Bayer has dropped its appeal to a ruling that quashed an extension for its patent covering an oral contraceptive, after the Full Court dealt drug makers a blow in two separate cases on how patent term extensions should be calculated.